All authors report no real or perceived conflicts of interest that could affect the study design, collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the manuscript for publication. For full disclosure, we provide the additional list of authors’ other funding not directly related to this study. DA is a consultant for Baxter, Nuwellis, Medtronic Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from NIH, Baxter, Nuwellis, Medtronic, Bioporto, and Seastar. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow. MS is supported in part by the Indiana University School of Medicine Physician Scientist Initiative and the NIH/NHLBI and NIH/NIDDK. JRC is supported by the NIH/NIDDK, consultant for Medtronics. CS MWH JRC DJA SM DS and MCS are board members of the Neonatal Kidney Collaborative. The authors have no financial disclosures. The funding sources for this study had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Patient consent was not required for this study, IRB approved at Indiana University School of Medicine.